163:
404:
248:
133:
223:
219:
394:
199:
158:
309:. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic
325:
of 1.784, ranking it 164th out of 211 in the category
Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy.
191:
187:
399:
342:
86:
36:
240:
146:
389:
94:
137:
121:
318:
236:
142:
125:
313:
to hormonal or biological response modalities. The journal has 10 issues per year and the current
270:
264:
372:
286:
211:
8:
80:
306:
257:
314:
302:
154:
56:
383:
322:
106:
310:
17:
207:
346:
228:
41:
172:
405:
Lippincott
Williams & Wilkins academic journals
305:, which aims to promote and encourage research on
162:
381:
16:For the drugs used to treat cancer, see
317:is Mels Sluyser. According to the 2014
382:
395:Academic journals established in 1990
13:
14:
416:
364:
87:Lippincott Williams & Wilkins
161:
335:
1:
328:
7:
10:
421:
15:
400:English-language journals
283:
278:
255:
183:
171:
117:
103:
93:
79:
71:
66:
55:
47:
35:
319:Journal Citation Reports
118:Standard abbreviations
321:, the journal has an
301:is an international
67:Publication details
32:
343:"Journal Homepage"
307:anti-cancer agents
26:
390:Oncology journals
298:Anti-Cancer Drugs
294:
293:
178:Anti-Cancer Drugs
29:Anti-Cancer Drugs
412:
376:
375:
373:Official website
358:
357:
355:
354:
345:. Archived from
339:
287:Journal homepage
267:
260:
251:
167:
165:
164:
109:
33:
30:
25:
23:Academic journal
420:
419:
415:
414:
413:
411:
410:
409:
380:
379:
371:
370:
367:
362:
361:
352:
350:
341:
340:
336:
331:
315:editor in chief
303:medical journal
274:
269:
263:
256:
227:
186:
185:
141:
120:
119:
110:
105:
89:
28:
24:
21:
12:
11:
5:
418:
408:
407:
402:
397:
392:
378:
377:
366:
365:External links
363:
360:
359:
333:
332:
330:
327:
292:
291:
290:
289:
281:
280:
276:
275:
261:
253:
252:
181:
180:
175:
169:
168:
115:
114:
111:
104:
101:
100:
97:
91:
90:
85:
83:
77:
76:
73:
69:
68:
64:
63:
60:
53:
52:
49:
45:
44:
39:
22:
9:
6:
4:
3:
2:
417:
406:
403:
401:
398:
396:
393:
391:
388:
387:
385:
374:
369:
368:
349:on 2003-11-10
348:
344:
338:
334:
326:
324:
323:impact factor
320:
316:
312:
308:
304:
300:
299:
288:
285:
284:
282:
277:
272:
268: (print)
266:
262:
259:
254:
250:
246:
242:
238:
234:
230:
225:
221:
217:
213:
209:
205:
201:
197:
193:
189:
182:
179:
176:
174:
170:
160:
156:
152:
148:
144:
139:
135:
131:
127:
123:
116:
112:
108:
107:Impact factor
102:
98:
96:
92:
88:
84:
82:
78:
74:
70:
65:
61:
58:
54:
50:
46:
43:
40:
38:
34:
31:
19:
351:. Retrieved
347:the original
337:
311:chemotherapy
297:
296:
295:
244:
232:
215:
203:
195:
177:
150:
129:
113:1.784 (2014)
75:1990–present
62:Mels Sluyser
27:
18:Chemotherapy
273: (web)
384:Categories
353:2010-02-17
329:References
155:MathSciNet
37:Discipline
271:1473-5741
265:0959-4973
95:Frequency
81:Publisher
184:Indexing
134:Bluebook
59: by
48:Language
42:Oncology
243:)
214:)
202:)
149:)
128:)
99:10/year
72:History
51:English
249:Scopus
245:·
233:·
231:
216:·
204:·
196:·
194:
151:·
130:·
57:Edited
279:Links
247:
235:
218:
208:JSTOR
206:
198:
188:CODEN
173:ISO 4
153:
132:
122:ISO 4
258:ISSN
229:MIAR
220:LCCN
200:alt2
241:alt
237:NLM
224:alt
212:alt
192:alt
159:alt
147:alt
143:NLM
138:alt
126:alt
386::
356:.
239:(
226:)
222:(
210:(
190:(
166:)
157:(
145:(
140:)
136:(
124:(
20:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.